SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Thomas J Pittman who wrote (11304)8/17/1999 10:03:00 AM
From: LJM  Read Replies (1) | Respond to of 17367
 
I'm sure this has probably been posted. <<Tom Costello on CNBC said Xoma has received bad news from the FDA which may prevent them from seeking a BLA for their drug Neuprex.>> This is most likely their take on the Bloomberg report, but damaging just the same.

This is certainly the most unique method of releasing info I've ever seen!

LJM



To: Thomas J Pittman who wrote (11304)8/17/1999 10:51:00 AM
From: LLCF  Respond to of 17367
 
Is there a chance that this whole thing has been a mis-representation of what's taking place, and that the data is actually good??? Or is that possibility now off the table, and data marginal???

DAK


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News